Next Article in Journal
Pulmonary Embolism in the Cancer Associated Thrombosis Landscape
Next Article in Special Issue
The Role of Genetically Modified Human Feeder Cells in Maintaining the Integrity of Primary Cultured Human Deciduous Dental Pulp Cells
Previous Article in Journal
Extraperitoneal Laparoscopic Approach in Inguinal Hernia—The Ideal Solution?
Previous Article in Special Issue
Clinical Islet Transplantation Covered by Health Insurance in Japan
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Functional Outcomes after Selective Clamping in Robot-Assisted Partial Nephrectomy

1
Department of Urology, Fujita-Health University School of Medicine, Nagoya 470-1192, Japan
2
Okazaki Medical Center, Department of Urology, Fujita Health University, Okazaki 444-0827, Japan
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2022, 11(19), 5648; https://doi.org/10.3390/jcm11195648
Submission received: 29 August 2022 / Revised: 22 September 2022 / Accepted: 24 September 2022 / Published: 25 September 2022
(This article belongs to the Special Issue Selected Papers from the JSOPB 2021-2022)

Abstract

:
This study aimed to assess the risks and benefits of selective clamping in robot-assisted partial nephrectomy (RAPN). We retrospectively analyzed 372 patients who had undergone RAPN at our hospital between July 2010 and March 2021. After propensity score matching between the full and selective clamping groups, perioperative outcomes and postoperative preservation ratio of the estimated glomerular filtration rate (eGFR) were compared at 6 and 12 months of follow-up. After propensity score matching, we evaluated 47 patients from each group. While no significant differences were observed in surgical time, warm ischemia time, or incidence rates of all grades of complications between the two cohorts, the estimated blood loss (EBL) was significantly lower in the full clamping group than in the selective clamping group (30 vs. 60, p = 0.046). However, no significant intergroup differences were observed in the postoperative preservation ratio of eGFR at 6 or 12 months of follow-up (full clamping 94.0% vs. selective clamping 92.7%, p = 0.509, and full clamping 92.0% vs. selective clamping 91.6%, p = 0.476, respectively). Selective clamping resulted in higher EBL rates than did full clamping in RAPN. However, selective clamping provided no renal functional advantage over full clamping in our propensity-score-matched cohort.

1. Introduction

Partial nephrectomy (PN) is the standard treatment for small renal tumors as the long-term oncological and functional outcomes are superior to those of radical nephrectomy [1,2]. According to a comprehensive systematic review and meta-analysis on PN, robot-assisted partial nephrectomy (RAPN) delivers mostly superior and at a minimum equivalent outcome compared to open and laparoscopic PN [3].
Multiple factors, including baseline function, amount of preserved parenchyma, and warm ischemia time (WIT), affect short- and long-term renal function after RAPN. Of these, WIT is considered a primary factor, and WIT > 25 min is particularly associated with a significant risk of new-onset stage IV chronic kidney disease [4].
Selective renal artery clamping is an alternative surgical technique to full clamping, that involves isolating and clamping only those renal arterial branches that directly supply the renal tumor. Selective clamping is performed over full clamping primarily due to better renal functional outcomes. Recently, several studies have evaluated the effectiveness and ability of performing selective clamping in RAPN [5,6,7,8,9,10,11,12,13,14,15,16,17]; however, it remains controversial regarding renal function after RAPN. Moreover, the follow-up period of was short, at approximately 6 months.
In this work, perioperative outcomes and postoperative preservation ratio of the estimated glomerular filtration rate (eGFR) between selective and full clamping groups were compared at 6 and 12 months of follow-up to assess the risks and benefits of selective clamping in RAPN, using propensity-score-matched analysis.

2. Materials and Methods

2.1. Patient Population

In this study, 375 patients who underwent RAPN between July 2010 and March 2021 at our hospital were enrolled. After exclusions due to incomplete data or conversion to radical nephrectomy, 372 patients (full clamping, 325; selective clamping, 47) were included. A 1:1 propensity-score-matched analysis was performed, and 47 patients from each group were evaluated (Figure 1).

2.2. Surgery

To construct 3D images for intraoperative navigation, all patients underwent unenhanced abdominal CT as well as four-phase dynamic contrast-enhanced (CE) CT examinations using ultra-high-resolution computed tomography (UHR-CT) or area-detector CT (ADCT). CT images were obtained using a four-phase dynamic CE-CT examination of each CT system. In the present study, ADCT was used for the initial cases (July 2010 to September 2018), and UHR-CT was used for the latter cases (October 2018 to March 2021). All data were obtained via an intraoperative navigation system using TilePro software.
All RAPN procedures were performed using the da Vinci Xi Surgical System (Intuitive Surgical, Sunnyvale, CA, USA) as previously described [18]. Briefly, the tumor was resected within 2–5 mm of the parenchymal margin. For the inner renorrhaphy layer, the collecting system and large vessels were closed using 3-0 V-Loc sutures. Then, if needed, parenchymal sutures were performed using 2-0 V-Loc, as required. The branch or branches of the renal artery that can supply the renal tumor were identified using UHR-CT or ADCT, and then the selective arterial clamping was performed. When performing the selective clamping in RAPN, the branches of the artery toward the renal tumor were appropriately exposed and clamped with the bulldog. In some cases, intravenous indocyanine green was administered after selective clamping to confirm the region of ischemia using the FIREFLY system (Intuitive Surgical, Sunnyvale, CA, USA).
All surgeons who completed the Japan-approved da Vinci certification program performed RAPN.

2.3. Data Collection

Data were collected preoperatively and at 6 and at 12 months of follow-up. Patient characteristics included age, sex, body mass index (BMI), and American Society of Anesthesiologists (ASA) score. Clinical disease characteristics included tumor side, surgical approach, tumor size, RENAL score [19], presence of a hilar or cystic tumor, and eGFR (mL/min/1.73 m2), which was calculated using the Modification of Diet in Renal Disease equation [20]. Surgical parameters included surgical time, console time, WIT, estimated blood loss (EBL), negative surgical margins, pathology, all grades of complications (Clavien–Dindo classification), and the presence of ≥3 complications (Clavien–Dindo classification). Trifecta achievement was defined as WIT ≤ 25 min, no complications, and negative surgical margins [21].
The protocol of this study was approved by the ethics committee of our institution (HM22-176), and the study was performed in accordance with the ethical standards laid down in the most recent version of the Declaration of Helsinki. The need for informed consent from all patients included in this study was waived because of the retrospective design.

2.4. Statistical Analyses

Due to inherent differences in baseline patient and disease characteristics between the full and selective clamping groups, we performed 1:1 propensity-score-matched analysis to adjust for imbalances in the confounding factors (age, sex, BMI, ASA score, eGFR, tumor side, approach, tumor size, RENAL score, hilar tumor, and cystic tumor). The propensity scores for each patient were calculated using multivariable logistic regression. Nearest neighbor matching was performed using calipers with a width equal to 0.2 times the standard deviation of the logit of the propensity scores. Intergroup comparisons were performed using a Mann–Whitney U-test, chi-squared test, or Fisher’s exact test. All data were analyzed using IBM SPSS Statistics version 23 (SPSS Japan Inc., Tokyo, Japan), and p values < 0.05 were considered statistically significant.

3. Results

3.1. Clinical Characteristics of the Patients

Patient characteristics, including age, sex, BMI, ASA score, preoperative eGFR, tumor side, surgical approach, tumor size, RENAL score, and the presence of hilar or cystic tumors were compared between the full and selective clamping groups, before and after matching. In the pre-matching cohort, only the tumor side showed a significant difference (p = 0.029), whereas no significant differences were observed between the full and selective clamping groups in the post-matching cohort (Table 1).

3.2. Perioperative Outcomes

Following propensity score matching, we compared intergroup perioperative factors. As shown in Table 2, perioperative factors, including surgical time, console time, WIT, EBL, negative surgical margins, pathology, grades of complications, and Clavien–Dindo classification ≥ 3 did not show any differences between the two groups; however, EBL was significantly decreased in the full clamping group than in the selective clamping group (30 vs. 60, p = 0.046). Trifecta achievement was observed in 93.6% of patients in the full clamping group and 80.9% in the selective clamping group, with no significant difference (p = 0.120).

3.3. Renal Functional Outcomes

There were no significant differences in the preservation ratio of eGFR between the two groups at the 6- or 12-month follow-up (full clamping 94.0% vs. selective clamping 92.7%, p = 0.509, and full clamping 92.0% vs. selective clamping 91.6%, p = 0.476, respectively) (Figure 2).
We then assessed the effect of WIT on renal function, regarding clamping. As the median WIT was 16 min in both groups, the preservation ratio of eGFR under or over 16 min of WIT was examined at the 6- or 12-month follow-up. In the category of WIT < 16 min, no significant intergroup differences were observed in the preservation ratio of eGFR at 6 or 12 months (full clamping 86.8% vs. selective clamping 94.1%, p = 0.381, and full clamping 94.3% vs. selective clamping 89.5%, p = 0.365, respectively) (Figure 3A,B). In the category of WIT > 16 min, no significant intergroup differences were observed in the preservation ratio of eGFR at 6 or 12 months (full clamping 95.6% vs. selective clamping 91.8%, p = 0.092, and full clamping 91.3% vs. selective clamping 92.9%, p = 0.938, respectively) (Figure 3C,D).

4. Discussion

Recently, studies have assessed the effectiveness and utility of selective clamping in RAPN [5,6,7,8,9,10,11,12,13,14,15,16,17]. Regarding renal function after RAPN, while some studies reported a short-term reduction in eGFR in selective clamping [6,7,8,12,13,14], others did not demonstrate improved renal function [9,11]. Moreover, Zhang L. et al. indicated patients undergoing PN with selective clamping had longer surgical time and higher EBL as compared with full clamping [15].
Of the studies, the first randomized controlled trial named EMERALD was reported to assess the impact of super-selective versus global ischemia directly on the operated kidney in RAPN using DMSA scintigraphy [17]. They concluded that super-selective RAPN using near-infrared fluorescence did not provide better renal function preservation than renal artery clamping in non-selected patients at the 6-month follow-up, based on single-surgeon expertise. Additionally, the role of systematic super-selective RAPN was unclear, given the higher vascular injury risks.
Badani et al. evaluated the outcomes of selective arterial clamping in patients with a solitary kidney to remove the influence of a contralateral kidney and compared them to those of full clamping in RAPN [5]. They reported that selective clamping did not appear to provide any functional advantage over full clamping, with similar intra- and postoperative outcomes.
The results obtained from these recent reports were inadequate for assessing the benefits of renal function in selective clamping in RAPN due to the short follow-up period (approximately 6 months). Moreover, none of the studies focused on WIT when assessing the functional impact of selective clamping in RAPN.
Therefore, we focused on the follow-up period, WIT, and perioperative outcomes and assessed the risks and benefits of selective clamping in RAPN.
Perioperative outcomes and renal function at 6 and 12 months after RAPN were compared between the selective and full clamping groups after propensity score matching. Our results indicated that among perioperative outcomes, only the EBL was significantly lowered in the full clamping group compared to the selective clamping group. With respect to renal function, no significant differences were observed in the postoperative preservation ratio of eGFR at the 6- or 12-month follow-up between the two groups.
Previous studies have suggested selective clamping might provide some benefits with a longer WIT in RAPN; therefore, we assessed the effect of WIT on renal function in the category of clamping by dividing the two groups with median cut-off values (16 min). In the category of WIT < 16 min, no significant intergroup differences were observed in the preservation ratio of eGFR at 6 or 12 months. Moreover, in the category of WIT > 16 min, no significant intergroup differences were observed in the preservation ratio of eGFR at 6 or 12 months. These results indicated that WIT in selective clamping did not affect renal function after RAPN.
This study has several limitations. First, this was a retrospective, small, single-institution study that lacked well-designed analyses. In particular, we were unable to perform a technetium-99m diethylene triamine pentaacetic acid (Tc-99m DTPA) diuretic renal scan for precise evaluation of renal function. Second, to adjust for clinical and demographic imbalances, we performed matched-pair analysis, which resulted in a small sample size. Third, although all our surgeons have sufficient experience in performing RAPN, the technical proficiency of the operators may have varied.

5. Conclusions

Selective clamping resulted in higher rates of EBL than in full clamping in RAPN. However, selective clamping did not provide any advantage in renal functional over full clamping after RAPN.

Author Contributions

Conceptualization, K.T., M.K. and R.S.; data curation, K.T., M.K., T.N., M.T., K.Z., M.I., H.S., M.S. and R.S.; methodology, K.T., M.K., M.S. and R.S.; project administration, K.T., M.K., M.S. and R.S.; resources, K.T., M.K., M.S. and R.S.; software, K.T., M.K., M.S. and R.S.; supervision, K.T., M.K., M.S. and R.S.; validation, K.T., M.K., M.S. and R.S.; visualization, K.T. and M.K.; writing—original draft, K.T. and M.K.; writing—review and editing, K.T. and M.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by Fujita Health University Ethics Review Committee (HM22-176).

Informed Consent Statement

The need for informed consent from all patients included in this study was waived because of the retrospective design.

Data Availability Statement

No new data were created or analyzed in this study. Data sharing is not applicable to this article.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Scosyrev, E.; Messing, E.M.; Sylvester, R.; Campbell, S.; Van Poppel, H. Renal function after nephron-sparing surgery versus radical nephrectomy: Results from EORTC randomized trial 30904. Eur. Urol. 2014, 65, 372–377. [Google Scholar] [CrossRef]
  2. Van Poppel, H.; Da Pozzo, L.; Albrecht, W.; Matveev, V.; Bono, A.; Borkowski, A.; Colombel, M.; Klotz, L.; Skinner, E.; Keane, T.; et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur. Urol. 2011, 59, 543–552. [Google Scholar] [CrossRef] [PubMed]
  3. Cacciamani, G.E.; Medina, L.G.; Gill, T.; Abreu, A.; Sotelo, R.; Artibani, W.; Gill, I.S. Impact of Surgical Factors on Robotic Partial Nephrectomy Outcomes: Comprehensive Systematic Review and Meta-Analysis. J. Urol. 2018, 200, 258–274. [Google Scholar] [CrossRef]
  4. Thompson, R.H.; Lane, B.R.; Lohse, C.M.; Leibovich, B.C.; Fergany, A.; Frank, I.; Gill, I.S.; Blute, M.L.; Campbell, S.C. Renal function after partial nephrectomy: Effect of warm ischemia relative to quantity and quality of preserved kidney. Urology 2012, 79, 356–360. [Google Scholar] [CrossRef] [PubMed]
  5. Badani, K.K.; Kothari, P.D.; Okhawere, K.E.; Eun, D.; Hemal, A.; Abaza, R.; Porter, J.; Lovallo, G.; Ahmed, M.; Munver, R.; et al. Selective clamping during robot-assisted partial nephrectomy in patients with a solitary kidney: Is it safe and does it help? BJU Int. 2020, 125, 893–897. [Google Scholar] [CrossRef]
  6. Bjurlin, M.A.; McClintock, T.R.; Stifelman, M.D. Near-infrared fluorescence imaging with intraoperative administration of indocyanine green for robotic partial nephrectomy. Curr. Urol. Rep. 2015, 16, 20. [Google Scholar] [CrossRef]
  7. Furukawa, J.; Miyake, H.; Hinata, N.; Muramaki, M.; Tanaka, K.; Fujisawa, M. Renal Functional and Perioperative Outcomes of Selective Versus Complete Renal Arterial Clamping During Robot-Assisted Partial Nephrectomy: Early Single-Center Experience With 39 Cases. Surg. Innov. 2016, 23, 242–248. [Google Scholar] [CrossRef] [PubMed]
  8. Harke, N.; Schoen, G.; Schiefelbein, F.; Heinrich, E. Selective clamping under the usage of near-infrared fluorescence imaging with indocyanine green in robot-assisted partial nephrectomy: A single-surgeon matched-pair study. World J. Urol. 2014, 32, 1259–1265. [Google Scholar] [CrossRef] [PubMed]
  9. Komninos, C.; Shin, T.Y.; Tuliao, P.; Han, W.K.; Chung, B.H.; Choi, Y.D.; Rha, K.H. Renal function is the same 6 months after robot-assisted partial nephrectomy regardless of clamp technique: Analysis of outcomes for off-clamp, selective arterial clamp and main artery clamp techniques, with a minimum follow-up of 1 year. BJU Int. 2015, 115, 921–928. [Google Scholar] [CrossRef]
  10. Martin, G.L.; Warner, J.N.; Nateras, R.N.; Andrews, P.E.; Humphreys, M.R.; Castle, E.P. Comparison of total, selective, and nonarterial clamping techniques during laparoscopic and robot-assisted partial nephrectomy. J. Endourol. 2012, 26, 152–156. [Google Scholar] [CrossRef]
  11. Mattevi, D.; Luciani, L.G.; Mantovani, W.; Cai, T.; Chiodini, S.; Vattovani, V.; Puglisi, M.; Malossini, G. Fluorescence-guided selective arterial clamping during RAPN provides better early functional outcomes based on renal scan compared to standard clamping. J. Robot. Surg. 2019, 13, 391–396. [Google Scholar] [CrossRef]
  12. McClintock, T.R.; Bjurlin, M.A.; Wysock, J.S.; Borofsky, M.S.; Marien, T.P.; Okoro, C.; Stifelman, M.D. Can selective arterial clamping with fluorescence imaging preserve kidney function during robotic partial nephrectomy? Urology 2014, 84, 327–332. [Google Scholar] [CrossRef] [PubMed]
  13. Paulucci, D.J.; Rosen, D.C.; Sfakianos, J.P.; Whalen, M.J.; Abaza, R.; Eun, D.D.; Krane, L.S.; Hemal, A.K.; Badani, K.K. Selective arterial clamping does not improve outcomes in robot-assisted partial nephrectomy: A propensity-score analysis of patients without impaired renal function. BJU Int. 2017, 119, 430–435. [Google Scholar] [CrossRef] [PubMed]
  14. Taweemonkongsap, T.; Suk-Ouichai, C.; Chotikawanich, E.; Jitpraphai, S.; Woranisarakul, V.; Ramart, P.; Phinthusophon, K.; Amornvesukit, T.; Leewansangtong, S.; Srinualnad, S.; et al. The Impact of Arterial Clamping Technique in Robot-Assisted Partial Nephrectomy on Renal Function and Surgical Outcomes: Six-Year Experience at Siriraj Hospital, Thailand. Urol. Int. 2018, 100, 301–308. [Google Scholar] [CrossRef]
  15. Zhang, L.; Wu, B.; Zha, Z.; Zhao, H.; Yuan, J.; Jiang, Y. Comparison of selective and main renal artery clamping in partial nephrectomy of renal cell cancer: A PRISMA-compliant systematic review and meta-analysis. Medicine 2018, 97, e11856. [Google Scholar] [CrossRef]
  16. Desai, M.M.; de Castro Abreu, A.L.; Leslie, S.; Cai, J.; Huang, E.Y.; Lewandowski, P.M.; Lee, D.; Dharmaraja, A.; Berger, A.K.; Goh, A.; et al. Robotic partial nephrectomy with superselective versus main artery clamping: A retrospective comparison. Eur. Urol. 2014, 66, 713–719. [Google Scholar] [CrossRef]
  17. Long, J.A.; Fiard, G.; Giai, J.; Teyssier, Y.; Fontanell, A.; Overs, C.; Poncet, D.; Descotes, J.L.; Rambeaud, J.J.; Moreau-Gaudry, A.; et al. Superselective Ischemia in Robotic Partial Nephrectomy Does Not Provide Better Long-term Renal Function than Renal Artery Clamping in a Randomized Controlled Trial (EMERALD): Should We Take the Risk? Eur. Urol. Focus 2021, 8, 769–776. [Google Scholar] [CrossRef]
  18. Takahara, K.; Sumitomo, M.; Fukaya, K.; Jyoudai, T.; Nishino, M.; Hikichi, M.; Nukaya, T.; Zennami, K.; Ichino, M.; Fukami, N.; et al. Predictors for trifecta achievement of robot-assisted partial nephrectomy in high-complexity tumors (Preoperative Aspects and Dimensions Used for an Anatomical score >/=10). Asian J. Endosc. Surg. 2020, 13, 390–396. [Google Scholar] [CrossRef]
  19. Kutikov, A.; Uzzo, R.G. The RENAL nephrometry score: A comprehensive standardized system for quantitating renal tumor size, location and depth. J. Urol. 2009, 182, 844–853. [Google Scholar] [CrossRef]
  20. Levey, A.S.; Bosch, J.P.; Lewis, J.B.; Greene, T.; Rogers, N.; Roth, D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med. 1999, 130, 461–470. [Google Scholar] [CrossRef]
  21. Khalifeh, A.; Autorino, R.; Hillyer, S.P.; Laydner, H.; Eyraud, R.; Panumatrassamee, K.; Long, J.A.; Kaouk, J.H. Comparative outcomes and assessment of trifecta in 500 robotic and laparoscopic partial nephrectomy cases: A single surgeon experience. J. Urol. 2013, 189, 1236–1242. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Flowchart of the patients in the study.
Figure 1. Flowchart of the patients in the study.
Jcm 11 05648 g001
Figure 2. Patients’ functional outcomes. (A) 6 months; (B) 12 months. Full clamping vs. selective clamping, mean with standard deviation.
Figure 2. Patients’ functional outcomes. (A) 6 months; (B) 12 months. Full clamping vs. selective clamping, mean with standard deviation.
Jcm 11 05648 g002
Figure 3. Preservation ratio of eGFR. Category of WIT<16 min ((A) 6 months, (B) 12 months). Category of WIT>16 min ((C) 6 months, (D) 12 months). Full clamping vs. selective clamping, mean with standard deviation.
Figure 3. Preservation ratio of eGFR. Category of WIT<16 min ((A) 6 months, (B) 12 months). Category of WIT>16 min ((C) 6 months, (D) 12 months). Full clamping vs. selective clamping, mean with standard deviation.
Jcm 11 05648 g003
Table 1. Patients’ clinical characteristics.
Table 1. Patients’ clinical characteristics.
Pre-MatchingPost-Matching
Median (IQR) or n (%)Full Clamping (n = 325)Selective Clamping (n = 47)p ValueFull Clamping (n = 47)Selective Clamping (n = 47)p Value
Age 62 (53–70)60 (51–67)0.390 58 (46–65)60 (51–67)0.222
Sex (%)
Male236 (72.6)33 (70.2)0.72933 (70.2)33 (70.2)1.000
Female89 (27.4)14 (29.8)14 (29.8)14 (29.8)
BMI, kg/m224 (22–26)24 (22–26)0.74924 (22–27)24 (22–26)0.349
ASA score
1101 (31.1)22 (46.8)0.074 27 (57.4)22 (46.8)0.698
2217 (66.8)24 (51.1)19 (40.4)24 (51.1)
37 (2.2)1 (2.1)1 (2.1)1 (2.1)
eGFR, mL/min/1.73 m269.6 (58.9–80.2)66.2 (51.9–77.1)0.11566.5 (56.5–78.2)66.2 (51.9–77.1)0.675
Tumor side
Right158 (48.6)31 (66.0)0.02930 (63.8)31 (66.0)1.000
Left167 (51.4)16 (34.0)17 (36.2)16 (34.0)
Approach
Transperitoneal156 (48.0)27 (57.4)0.27522 (46.8)27 (57.4)0.409
Retroperitoneal169 (52.0)20 (42.6)25 (53.2)20 (42.6)
Tumor size, mm29 (22–37)30 (22–35)0.83425 (20–33)30 (22–35)0.193
RENAL score
4–6149 (45.8)15 (31.9)0.18621 (44.7)15 (31.9)0.136
7–9155 (47.7)29 (61.7)26 (55.3)29 (61.7)
10–1221 (6.5)3 (6.4)0 (0)3 (6.4)
Hilar tumor59 (18.2)10 (21.3)0.6888 (17.0)10 (21.3)0.794
Cystic tumor48 (14.8)8 (17.0)0.6655 (10.6)8 (17.0)0.552
Table 2. Patients’ surgical outcomes.
Table 2. Patients’ surgical outcomes.
Post-Matching
Median (IQR) or n (%)Full Clamping (n = 47)Selective Clamping (n = 47)p Value
Surgical time, min165 (143–198)152 (136–180)0.208
Console time, min114 (88–132)102 (90–132)0.623
WIT, min16 (12–19)16 (13–19)0.738
EBL, mL30 (15–100)60 (30–112)0.046
Negative surgical margins47 (100)47 (100)1.000
Pathology, clear cell carcinoma13 (27.7)14 (29.8)1.000
All grades of complications2 (4.3)7 (14.9)0.158
Clavien–Dindo ≥ grade 31 (2.1)3 (6.4)0.617
Trifecta achievement44 (93.6)38 (80.9)0.120
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Takahara, K.; Kusaka, M.; Nukaya, T.; Takenaka, M.; Zennami, K.; Ichino, M.; Sasaki, H.; Sumitomo, M.; Shiroki, R. Functional Outcomes after Selective Clamping in Robot-Assisted Partial Nephrectomy. J. Clin. Med. 2022, 11, 5648. https://doi.org/10.3390/jcm11195648

AMA Style

Takahara K, Kusaka M, Nukaya T, Takenaka M, Zennami K, Ichino M, Sasaki H, Sumitomo M, Shiroki R. Functional Outcomes after Selective Clamping in Robot-Assisted Partial Nephrectomy. Journal of Clinical Medicine. 2022; 11(19):5648. https://doi.org/10.3390/jcm11195648

Chicago/Turabian Style

Takahara, Kiyoshi, Mamoru Kusaka, Takuhisa Nukaya, Masashi Takenaka, Kenji Zennami, Manabu Ichino, Hitomi Sasaki, Makoto Sumitomo, and Ryoichi Shiroki. 2022. "Functional Outcomes after Selective Clamping in Robot-Assisted Partial Nephrectomy" Journal of Clinical Medicine 11, no. 19: 5648. https://doi.org/10.3390/jcm11195648

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop